Joseph P. Pellegrino, Jr. Joins Precision Optics Board
Precision Optics Welcomes New Board Member Joseph P. Pellegrino, Jr.
Precision Optics Corporation, Inc. (NASDAQ: POCI), a prominent name in designing and manufacturing advanced optical instruments for medical and defense/aerospace sectors, is pleased to share the exciting news about the latest addition to its Board of Directors. Joseph P. "JJ" Pellegrino, Jr. has been appointed, and his expertise is expected to contribute significantly to the company’s strategic direction.
Enhanced Expertise on the Board
JJ Pellegrino is not just joining the board; he will also assume the role of Chairman of the Audit Committee. With decades of experience in both operational and financial roles, Pellegrino’s insight into the medical device industry is invaluable. His most recent position was as Chief Financial Officer at LeMaitre Vascular, Inc. (Nasdaq: LMAT), where he served from 2007 until early 2025, continuing to be an active board member there.
Pellegrino’s Background
His professional journey began in 2005 when he joined LeMaitre Vascular as Executive Vice President of Finance. His career also includes significant roles at Zoots, Inc., where he honed his operational strategies as Senior Vice President of Operations. His diverse professional background also includes experience in investment banking, where he worked with mergers and acquisitions at Lehman Brothers.
Vision for Growth
Peter Woodward, Chairman of Precision Optics, expressed enthusiasm regarding Pellegrino’s appointment. He stated, "We are thrilled to have JJ join our board. His experience and strategic vision in the medical device space will provide critical insights that will foster our growth and adaptability in a fast-evolving market. His track record speaks volumes—he has successfully driven organizations through various stages of development, aligning with our goal of sustainable growth and operational excellence at Precision Optics."
Transition in Board Composition
With Mr. Pellegrino’s arrival on the board, there is a notable change as well. Peter Anania has retired from his position on the Board of Directors. Anania played a crucial role following the acquisition of Lighthouse Imaging, having been appointed to the board back in October 2021 and served as President and Chairman during that period.
Future Outlook for Precision Optics
Precision Optics Corporation, founded in 1982, is on a mission to innovate within the optics industry, particularly by leveraging proprietary technologies in micro-optics. The company is adept at navigating the complexities of both the healthcare and defense/aerospace sectors. By providing comprehensive services—from conceptual development through to large-scale manufacturing—Precision Optics meets the rigorous demands of today’s healthcare community.
Through its leading-edge design capabilities and unique production resources, the company continues to develop advanced solutions that enhance surgical procedures, particularly in minimally invasive surgery and effective 3D endoscopy systems. In addition to these critical applications, the company has built long-standing partnerships with top-tier medical device manufacturers, supplying an array of complex optical products.
Technical Capabilities and Applications
The company’s expertise doesn't stop there; Precision Optics is also focusing on defence/aerospace applications. Here, the emphasis is on delivering high-quality products while optimizing for size, weight, and power consumption. As markets evolve, Precision Optics stands ready to answer new demands with proficient engineering and innovation.
Company Contacts
For more information about Precision Optics and its recent developments, please contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800
Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
Email: poci@lythampartners.com
Frequently Asked Questions
Who is Joseph P. Pellegrino, Jr.?
Joseph P. Pellegrino, Jr. is the newly appointed member of the Board of Directors for Precision Optics, bringing significant industry expertise.
What positions has Pellegrino held before joining Precision Optics?
Before joining Precision Optics, Pellegrino served as Chief Financial Officer at LeMaitre Vascular, Inc. and has extensive experience in financial leadership and operational roles within the medical device industry.
What are the goals for Pellegrino as a board member?
His primary goals include driving sustainable growth, enhancing regulatory foresight, and fostering innovation within Precision Optics.
What experience does Precision Optics have in its market?
Precision Optics has been a leader in designing advanced optical instruments, leveraging technologies in both healthcare and defense/aerospace sectors since 1982.
How can I learn more about Precision Optics Corporation?
To learn more, individuals can visit Precision Optics’ official company website or reach out through provided company contacts.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.